ClinicalTrials.Veeva

Menu

Prevalence of Congenital Uterine Malformations (PUMA)

U

University of Nottingham

Status

Unknown

Conditions

Congenital Uterine Anomalies

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Aims: We plan to investigate how common uterine malformations are in high-risk women (with history of miscarriage or preterm delivery), by analysing different characteristics in these groups. This study will also investigate other ultrasound characteristics detected on these women. This study will point towards the possible mechanism of how uterine malformations may affect pregnancy outcomes.

Full description

Background: Congenital abnormally shaped wombs (uterine malformations) have long been thought to be more common in women with poor pregnancy outcomes, e.g. miscarriage (Rackow and Arici 2007) and preterm delivery (Tomazevic, Ban-Frangez et al. 2007). However, the true prevalence is difficult to assess as there are no universally agreed classification systems and some of the best investigations are invasive. In addition, previous prevalence studies have not examined the details of subfertility or pregnancy loss, such as duration of subfertility, the gestation of pregnancy loss, or miscarriage pattern.

Aims: We plan to investigate how common uterine malformations are in high-risk women (with history of miscarriage or preterm delivery), by analysing different characteristics in these groups. This study will also investigate other ultrasound characteristics detected on these women. This study will point towards the possible mechanism of how uterine malformations may affect pregnancy outcomes.

Methods: We plan to recruit women who have had miscarriage or preterm delivery into our study. A sample of women who had normal term deliveries will be recruited as comparison. All women will undergo one 3-dimensional ultrasound scan each.

Outcomes: The proportions of women with congenital uterine malformations will be determined. Any ultrasound-detected markers found especially in women with poor pregnancy outcomes may point towards how uterine malformations affect pregnancies.

Enrollment

246 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Women with a previous miscarriage

    • Age: 18 years old or more
    • Definition of miscarriage: the spontaneous pregnancy loss up until 24 weeks of gestation, where the pregnancy was confirmed histologically or with previous presence of a gestational sac with or without fetal pole and fetal heart activity on ultrasound scanning.
    • At least 8 weeks after the end of last pregnancy
  2. Women with preterm birth

    • Age: 18 years old or more
    • Definition of preterm birth: birth at less than 37 weeks of gestation.
    • At least 8 weeks after the end of last pregnancy
  3. Control group (women with term birth)

    • Age: 18 years old or more
    • Definition of term birth: birth at 37 or more weeks of gestation
    • At least 8 weeks after the end of last pregnancy

Exclusion criteria

  • Pregnant at the date of the 3D TVUS
  • Recent uterine or endometrial surgery
  • Women unable to tolerate 3D TVUS
  • Unable to give informed consent

Trial design

246 participants in 3 patient groups

Women with previous preterm birth
Description:
Women with history of preterm birth (birth of a baby of less than 37 weeks gestational age, where labour was spontaneous) regardless of past pregnancy history.
Women with previous miscarriage
Description:
Women with history of miscarriage (spontaneous pregnancy loss before 24 weeks of gestation), regardless of past pregnancy history.
Women with previous term births
Description:
Women with previous term births (37 or more weeks of gestation)

Trial contacts and locations

1

Loading...

Central trial contact

Yee Yin Chan, BMBS; Nicholas Raine-Fenning, MBChB PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems